Kenneth Frazier News
-
Merck & Co. Chief Executive Officer Kenneth Frazier said the drugmaker may be interested in buying Bausch & Lomb, the eye-care company for sale by Warburg Pincus LLC for at least $10 billion.
-
Get ready for the return of the $10 billion-plus drug deal.
-
Merck & Co. ’s Chief Executive Officer Kenneth Frazier , who took over the top leadership role on Jan. 1, said the company will make “tough” research spending decisions while developing innovative products.
-
Merck & Co., facing generic competition in August to its top-selling asthma drug Singulair, reported second-quarter profit that beat analyst estimates on higher sales of the diabetes medicines Januvia and Janumet.
-
Debbie Dingell, wife of Congressman John Dingell, Michigan Democrat, was reunited last night with Hydeia Broadbent, a thriving woman in her late 20s.
-
Merck & Co. Chief Executive Officer Kenneth Frazier said the company reduced its sales force in developed markets by 32 percent in 2010, while building up the staff in China, Brazil and Russia.
-
Merck & Co. , the second largest U.S. drugmaker, forecast 2011 earnings that missed analyst estimates and posted a fourth-quarter loss after taking a $1.7 billion charge to write down its experimental blood thinner.
-
President Barack Obama met today with Kenneth Frazier , chief executive officer of Merck & Co ., the nation’s second-largest drugmaker, the administration said in a statement.
-
Merck & Co. named Kenneth C. Frazier as president effective May 1, succeeding Richard T. Clark, who will continue as chairman and chief executive officer.
-
New chief executive officers at Merck & Co. and Pfizer Inc ., torn between profit demands of investors and the long-term funding needs of drug innovation, have chosen opposing strategies for future investment in research.
|
|
Most Popular on Bloomberg
|
| |
Rate this Page